Search for: "SANOFI-PHARMACEUTICALS, INC."
Results 41 - 60
of 216
Sort by Relevance
|
Sort by Date
11 Jun 2020, 11:30 pm
” Now the claims here are quite unsettling, especially considering that they were lodged in a defense brief, in an MDL, with many cases at stake, made on behalf of an important pharmaceutical company, represented by two large, capable national or international law firms. [read post]
17 May 2020, 2:57 am
Kat Friend Matt Swinn shed light on a complex case between the Commonwealth of Australia and the pharmaceutical manufacturer Sanofi. [read post]
3 Mar 2020, 4:00 am
In Novartis Pharmaceuticals Canada Inc. v. [read post]
19 Feb 2020, 4:03 pm
In 2017, Pfizer Inc. [read post]
18 Feb 2020, 4:00 am
Pfizer Canada ULC, 2020 FC 1, at para. 42. [3] See Sections 27(3)(b) and 28.3 of the Patent Act, RSC 1985, c P-4 [4] Burton Parsons Chemicals, Inc v Hewlett-Packard (Canada) Ltd, [1976] 1 SCR 555 at 563 [5] Apotex Inc v Sanofi-Synthelabo Canada Inc, 2008 SCC 61 at paragraph 37, [2008] 3 SCR 265; see also Bell Helicopter Textron Canada Limitée v Eurocopter, société par actions simplifiée, 2013 FCA 219 at paragraph 65; Mylan… [read post]
30 Jan 2020, 5:29 am
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]
30 Jan 2020, 5:29 am
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]
12 Sep 2019, 5:44 pm
In 2017, Pfizer Inc. [read post]
11 Apr 2019, 10:59 am
The compounds of the present invention can be combined with pharmaceutical carriers and administered in a variety of well-known pharmaceutical forms suitable for oral or parental administration to provide compositions useful in the treatment of cardiovascular disorders and particularly mammalian hypertension. (35) (citing Sanofi v Apotex/ramipril). [read post]
3 Oct 2018, 8:51 am
Amgen Inc. v. [read post]
29 Jun 2018, 7:50 am
Amphastar Pharmaceuticals, Inc. [read post]
20 Jun 2018, 4:12 am
Note that Meyerlustenberger Lachenal AG has been involved in this matter on behalf of Gilead) The Swiss dispute in a nutshell The Swiss litigation is about the validity of Gilead Sciences Inc. [read post]
5 Feb 2018, 9:59 pm
Mylan Pharmaceuticals, Inc. v. [read post]
17 Oct 2017, 6:09 pm
SANOFI, AVENTISUB LLC & ors. [read post]
5 Sep 2017, 7:45 am
According to DOJ’s press release: Pharmaceutical companies Mylan Inc. and Mylan Specialty L.P. have agreed to pay $465 million to resolve claims that they violated the False Claims Act by knowingly misclassifying EpiPen as a generic drug to avoid paying rebates owed primarily to Medicaid, the Justice Department announced today. [read post]
25 Aug 2017, 7:02 am
On Thursday, August 17, 2017, the Department of Justice, announced that Mylan Inc. and Mylan Specialty L.P. [read post]
25 Aug 2017, 7:02 am
On Thursday, August 17, 2017, the Department of Justice, announced that Mylan Inc. and Mylan Specialty L.P. [read post]
18 Aug 2017, 2:15 pm
Mylan Inc., et al.. [read post]
18 Aug 2017, 2:15 pm
Mylan Inc., et al.. [read post]
9 Jan 2017, 9:36 am
Sandoz, Inc., 135 S. [read post]
